BRISIGOTTI, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 3.508
EU - Europa 1.530
AS - Asia 1.413
SA - Sud America 323
AF - Africa 114
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 6.892
Nazione #
US - Stati Uniti d'America 3.443
SG - Singapore 473
VN - Vietnam 330
CN - Cina 298
IT - Italia 271
RU - Federazione Russa 266
BR - Brasile 257
FR - Francia 168
SE - Svezia 148
DE - Germania 137
IE - Irlanda 135
UA - Ucraina 128
HK - Hong Kong 101
GB - Regno Unito 81
FI - Finlandia 71
CI - Costa d'Avorio 56
IN - India 53
TR - Turchia 36
DK - Danimarca 33
ZA - Sudafrica 30
CA - Canada 28
MX - Messico 25
AR - Argentina 21
NL - Olanda 21
JP - Giappone 18
BD - Bangladesh 17
KR - Corea 17
MA - Marocco 17
IQ - Iraq 16
BE - Belgio 14
ES - Italia 13
PL - Polonia 13
EC - Ecuador 11
CL - Cile 10
PK - Pakistan 10
ID - Indonesia 7
VE - Venezuela 7
AT - Austria 6
PY - Paraguay 6
UZ - Uzbekistan 6
CO - Colombia 5
EG - Egitto 5
JM - Giamaica 5
PH - Filippine 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
TH - Thailandia 4
CH - Svizzera 3
EU - Europa 3
HR - Croazia 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
JO - Giordania 2
KE - Kenya 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
SM - San Marino 2
UY - Uruguay 2
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MT - Malta 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.892
Città #
Ashburn 503
Chandler 372
Singapore 310
Dallas 222
Des Moines 186
Fairfield 173
San Jose 146
Jacksonville 140
Dublin 135
New York 115
Boardman 114
Ho Chi Minh City 99
Hong Kong 96
Wilmington 86
Hanoi 85
Seattle 83
The Dalles 83
Council Bluffs 81
Woodbridge 73
Houston 68
Beijing 65
Cambridge 59
Munich 58
Los Angeles 57
Abidjan 55
Lawrence 52
Princeton 52
Ann Arbor 50
Lauterbourg 50
Moscow 45
San Mateo 41
Helsinki 35
Centro 31
Turin 26
São Paulo 25
London 24
Turku 24
Ancona 23
Orem 23
Buffalo 22
Pune 22
San Diego 22
Shanghai 21
Da Nang 20
Guangzhou 19
Haiphong 18
Johannesburg 18
Santa Clara 18
Chicago 16
Hefei 16
Chennai 14
Tolentino 14
Brussels 13
Marche 13
Tokyo 13
Wuhan 13
Brooklyn 12
Denver 12
Rome 11
Poplar 10
Warsaw 10
Washington 10
Montreal 9
Ascoli Piceno 8
Frankfurt am Main 8
Hải Dương 8
Manchester 8
Stockholm 8
Baghdad 7
Biên Hòa 7
Boston 7
Columbus 7
Menlo Park 7
Norwalk 7
Nuremberg 7
Phoenix 7
Atlanta 6
Cagliari 6
Guarulhos 6
Kilburn 6
Rio de Janeiro 6
Campinas 5
Cape Town 5
Curitiba 5
Huskvarna 5
Itaquaquecetuba 5
Salt Lake City 5
San Bernardo 5
San Francisco 5
Wuxi 5
Amsterdam 4
Bắc Ninh 4
Can Tho 4
Gainesville 4
Goiânia 4
Hangzhou 4
Hanover 4
Kyiv 4
Mexico City 4
Milan 4
Totale 4.542
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 317
I polimorfismi genetici nel melanoma cutaneo 216
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 179
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 155
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 153
Involvement of the oral cavity in psoriasis: results of a clinical study 152
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 148
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 147
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 147
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 147
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 141
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 138
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 136
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 136
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 133
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 132
Dermoscopic features of conjunctival melanocytic lesions 131
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 131
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 129
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 125
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region 124
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 124
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 123
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 123
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 121
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 120
Reticulated acanthoma with sebaceous differentiation 119
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 119
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 118
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 116
Relapsing acute generalized exanthematous pustolosis: a guess. 114
The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients 113
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 113
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 112
Topical application of fumaric acid esters improves appearance of nail psoriasis 112
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 111
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 110
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 110
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 109
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 109
Mycosis Fungoides-like Eruption and Infliximab 106
The switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group 105
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 105
Expression of nicotinamide N-methyltransferase in non-melanoma skin cancers 104
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 103
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 102
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 101
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 98
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 98
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 94
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 90
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 89
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 88
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 86
Phototherapy in Dermatology 83
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa 75
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 66
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation. 44
Totale 7.050
Categoria #
all - tutte 33.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021205 0 0 0 0 0 0 0 0 0 65 108 32
2021/2022425 12 75 22 9 16 24 12 40 23 11 72 109
2022/20231.054 81 125 82 89 56 273 3 57 193 5 68 22
2023/2024601 89 11 57 63 71 141 11 27 4 43 7 77
2024/20251.014 155 81 29 19 39 40 88 33 202 67 140 121
2025/20262.806 289 169 238 310 374 212 508 261 249 196 0 0
Totale 7.050